The European Medicines Agency (EMA) on Friday proposed a revision to its policy on accessing documents, extending the scope to include corporate documents, and increasing the publication of clinical data for pharmaceuticals. Since October 2016, EMA has published pharmaceutical trial data via its new website, including for: Mylan’s aripiprazole, published most recently on 31 January 2017,…
Sicor Biotech/Teva Baltic, the largest pharmaceutical company in Lithuania, is preparing to begin production of a new active medicinal ingredient to be used in the treatment of cancer. The ingredient, XM21, will be produced in the company’s Vilnius facility from this autumn. As Giedrius Žunda, the director of the Vilnius unit explains, XM21 is already…
An Iranian pharma company Monday broke ground on a plant it is building as a joint venture with Azerbaijan. Iran’s Darou Pakhsh Pharma Chem is building the $30 million plant in the Pirallahi Industrial Park, the Financial Tribune reports. The plant is projected to be commissioned in two years. Darou Pakhsh Pharma Chem last year…
Thanks to advances in science and technology, the research–based pharmaceutical industry is entering an exciting new era in medicines development: The Pharmaceutical Industry in Figures – Key Data 2016
Slovakian Government has granted Saneca Pharma EUR 1.5m to invest in “green” API manufacturing and anti-abuse technologies for it’s opiate-based drugs http://www.in-pharmatechnologist.com/Ingredients/Saneca-gets-Gov-grant-to-invest-in-API-plant
The only conference covering the entire CIS pharmaceutical sector including Kazakhstan, Uzbekistan, Moldova, Belarus, Armenia, Georgia, Azerbaijan, Kyrgyzstan, Tajikistan, Turkmenistan & more! More..
The Azerbaijani-Russian joint pharmaceutical plant will come to full production capacity in 2020, said Azerbaijan’s Economy Minister Shahin Mustafayev. He made the remarks Nov. 2 during the plant’s groundbreaking ceremony in the Pirallahi Industrial Park. This is Azerbaijan’s first pharmaceutical plant, said the minister, adding that a 10-percent share in the joint venture will be…
Within the framework of the Kazakh-Hungarian business forum the «Kaznex Invest» JSC, the JSC “International Research and Production Holding “Phytochemistry” and Hungarian company «PannonPharma LTD» signed a memorandum of understanding on organization and expansion of the production of original medicinal drugs based on plant matter in Karaganda. “Today we produce about 2 million ampules, about…
Informa Life Sciences’ Global Pharmaceutical Regulatory Affairs Summit, taking place on 27th – 29th October 2015 in Berlin, Germany, combines two previously separate events, ‘Regulatory Affairs in Emerging Markets’ and ‘Global eSubmissions’ to bring you increased networking and 3 highly focussed streams. Stream 1: Regulatory Affairs in Russia, CIS, Turkey and MENA Stream 2: Regulatory…
Private healthcare markets in Central Europe are still young markets replete with opportunities. There is substantial demand for such services in the countries analysed in the most recent PMR report “Private healthcare market in Central Europe 2016. Development forecasts for 2016-2021” because of the rise of the middle and upper classes and the increase in…